SCHEMBL7210230

SCHEMBL7210230

Fc1ccc(-c2cncnc2-c2ccncc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 2/20 0.59
MAPK10 P53779 2/20 0.59
MAPK14 Q16539 13/20 0.53
MAPK13 O15264 4/20 0.53
MAPK12 P53778 4/20 0.53
MAPK11 Q15759 4/20 0.53
CSNK1D P48730 1/20 0.50
CSNK1E P49674 1/20 0.50
RAF1 P04049 1/20 0.49
KIT P10721 1/20 0.48
GCGR P47871 1/20 0.47
CYP17A1 P05093 1/20 0.47
KDR P35968 1/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27503714 0.98 MAPK9 (0.57) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL31452825 0.86 ADORA1 (0.58) MAPK9MAPK10MAPK14CYP17A1ALDH1A1
SCHEMBL15023022 0.83 MAPK9 (0.59) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL5456395 0.81 MAPK9 (0.61) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL15022310 0.79 MAPK9 (0.55) MAPK9MAPK10MAPK14
SCHEMBL7210423 0.77 ADORA1 (0.51) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL29415419 0.76 CYP1A2 (0.45) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL7210550 0.76 ADORA1 (0.75) MAPK10MAPK14MAPK13MAPK12MAPK11
SCHEMBL7210472 0.76 MAPK14 (0.50) MAPK9MAPK10MAPK14MAPK13MAPK12
SCHEMBL7215179 0.76 MAPK14 (0.56) MAPK9MAPK10MAPK14MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1246858-A Substituted pyrimidine compounds and their use AMGEN INC (US) 2000-03-08 CN claimed
US-6610698-B2 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases AMGEN, INC. 2003-08-26 US disclosed
EP-1314731-A2 Substituted pyrimidine compounds and their use AMGEN INC. (US) 2003-05-28 EP disclosed
EP-1314732-A2 Substituted pyrimidine compounds and their use AMGEN INC. (US) 2003-05-28 EP disclosed
US-6410729-B1 ANALGESICS; ANTIDIABETIC AGENTS; ANTIINFLAMMATORY AGENTS AMGEN INC. 2002-06-25 US disclosed
CN-1246858-A Substituted pyrimidine compounds and their use AMGEN INC (US) 2000-03-08 CN disclosed
EP-0948497-A2 SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE Amgen inc. (US) 1999-10-13 EP disclosed
WO-1998024782-A2 SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AMGEN INC. (US) 1998-06-11 WO disclosed